MODERN DIAGNOSTIC & RESEARCH CENTRE
No DCF model value for MODERN DIAGNOSTIC & RESEARCH CENTRE yet.
A model value is not currently available for this company.
All values are mathematically derived from financial models and do not constitute buy, sell, or hold recommendations. Models rely on historical data and assumptions that may not reflect future outcomes. StockRank is not a registered investment advisor — always do your own research before making investment decisions.
360° view
The takeaway
A diagnostic-services provider with moderate revenue growth and positive margins, but profit has declined over five years and the shares have fallen well below their 52-week high. Valuation expectations are unavailable.
↗ Strengths
- Revenue grew at a three-year compound annual rate of about 13.9%, though five-year growth was slower at about 2.1%.
- Operating margin was 14.96% and net margin 6.32%, with return on equity at 8.97%.
- Promoter holding was 73% with no pledged shares reported as of the latest shareholding date.
↘ Risks to watch
- Five-year net profit declined at a compound annual rate of about 12%, and no three-year profit or EPS growth was available.
- The stock was about 42% below its 52-week high and down 23.9% over six months; momentum inputs were largely unavailable.
- No qualified DCF valuation model was available, and the overall score is not eligible for complete five-axis comparison.
Modern Diagnostic & Research Centre provides diagnostic and related healthcare testing services in India. Its offerings include laboratory services such as molecular diagnostics, histopathology, microbiology and biochemistry, alongside radiology services including MRI, CT, PET-CT, ultrasound and digital X-ray. Reported revenue segments cover diagnostics services, with earlier years split between pathology and radiology. Geographic reporting has included India, international operations and, in earlier periods, Uganda and Nigeria.
Key metrics
Latest reported · price-based figures use the EOD quote5 scoring axes
How cheaply the stock is priced relative to earnings, assets, and cash flows vs peers.
69/100How cheaply the stock is priced relative to earnings, assets, and cash flows vs peers.
- Market value of equity relative to reported shareholder equity. Asset quality, profitability and accounting practices affect how the ratio should be read.
- 1.50×
- Share price relative to earnings per share over the trailing 12 months. Growth, risk and one-off earnings can affect this ratio; it is not meaningful when earnings are nonpositive.
- 16.67×
- P/E divided by the earnings-growth rate used in the ratio. Its meaning depends on that growth period and whether growth is sustainable.
- —
- Enterprise value relative to the latest annual earnings before interest, tax, depreciation and amortisation. It includes debt in valuation but does not account for capital spending or all cash needs.
- 9.16×
- Reported annual operating cash flow as a percentage of current market value of equity. This is before capital spending, so it is not free cash flow.
- 4.36%
- Percentage difference between the saved valuation estimate and its reference share price. It depends on assumptions and is not a forecast return.
- —
Profitability, capital efficiency, and consistency of cash generation.
56/100Profitability, capital efficiency, and consistency of cash generation.
- Net profit as a percentage of revenue for the latest annual period. Tax, financing and one-off items can affect the margin.
- 6.32%
- Operating profit as a percentage of revenue for the latest annual period. It reflects operating profitability before financing and tax, and varies by industry.
- 14.96%
- A count of nine accounting checks covering profitability, financial position and operating efficiency. More checks passed does not guarantee future performance, and the measure is less suited to financial businesses.
- 3 / 9
- Operating profit relative to the capital used in the business. It indicates capital efficiency, but industry capital needs and accounting values affect comparisons.
- 11.21%
- Net profit relative to shareholder equity. Debt or a small equity base can raise this ratio without improving the underlying business.
- 8.97%
- Operating cash flow divided by common net profit for the same annual period. It shows how earnings translate into operating cash, but working-capital timing can move the ratio.
- 0.73×
- The share of observed annual periods with positive common earnings within the last ten years. It describes profit frequency, not the size or stability of those profits.
- 66.67%
- The middle annual return on capital employed from the five-year history. It reduces the influence of a single unusual year but can hide recent changes.
- 11.21%
Revenue and earnings growth rates across multiple time horizons.
39/100Revenue and earnings growth rates across multiple time horizons.
- Operating cash flow growth expressed as a compounded annual rate over 3 years. It smooths year-to-year changes and does not predict future growth.
- —
- Earnings-per-share growth expressed as a compounded annual rate over three years. Changes in share count and one-off profits can affect the rate.
- —
- Net profit growth expressed as a compounded annual rate over 3 years. It smooths year-to-year changes and does not predict future growth.
- —
- Net profit growth expressed as a compounded annual rate over 5 years. It smooths year-to-year changes and does not predict future growth.
- -12.04%
- Revenue change from the same quarter a year earlier. It reduces seasonal differences, but a weak comparison period can amplify growth.
- —
- Revenue growth expressed as a compounded annual rate over 3 years. It smooths year-to-year changes and does not predict future growth.
- 13.88%
- Revenue growth expressed as a compounded annual rate over 5 years. It smooths year-to-year changes and does not predict future growth.
- 2.07%
Balance sheet strength, leverage, and financial stability.
54/100Balance sheet strength, leverage, and financial stability.
- Cash and cash equivalents divided by borrowings. It shows how much borrowing is covered by reported cash, which may not all be freely available.
- 0.25×
- Current assets divided by current liabilities. It describes short-term balance-sheet coverage, but inventories and receivables may not turn into cash quickly.
- 1.00×
- Borrowings relative to shareholder equity. More borrowing can increase financing risk; the ratio has different meaning for lenders and is not useful with nonpositive equity.
- 0.63×
- Earnings available to cover interest expense, expressed as a multiple. It indicates interest-payment capacity but does not cover principal repayments or all cash needs.
- 5.58×
- The share of promoter holdings pledged as collateral. Pledging can create financing pressure if collateral values fall; zero pledging does not remove other risks.
- 0.00%
- The percentage of shares held by promoters. Ownership concentration can align interests but does not by itself establish governance quality.
- 73.00%
Recent price moves and changes in earnings and institutional ownership.
—/100Recent price moves and changes in earnings and institutional ownership.
- Change in the share of equity held by domestic institutional investors over one year, in percentage points. It describes ownership changes, not the cash they invested or future returns.
- —
- The latest quarterly operating margin minus the average of the preceding four quarters, in percentage points. It describes a margin change, not percentage growth in profit.
- —
- Net profit change from the same quarter a year earlier. One-off items and a small comparison-period profit can make the percentage unusually large.
- —
- Revenue change from the same quarter a year earlier. It reduces seasonal differences, but a weak comparison period can amplify growth.
- —
- Share-price change over one year. Past price performance does not predict future returns.
- —
- Share-price change over three years in total, not per year. Past price performance does not predict future returns.
- —
Peer Companies
Healthcare Service ProviderQuarterly Results
₹ Cr · per share in ₹| Particulars | Jun '25 | Sep '25 |
|---|---|---|
| − Revenue | ||
| Revenue | 22.50 | 20.69 |
| − Profitability | ||
| Operating Profit | 5.86 | 1.65 |
| OPM % | 26.05% | 7.96% |
| Profit Before Tax | 4.28 | 0.52 |
| − Bottom Line | ||
| Net Profit | 3.00 | 0.17 |
| EPS | 2.73 | 0.16 |
Income Statement
Annual · ₹ Cr · per share in ₹| Particulars | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| − Revenue | ||||||
| Revenue | 75.01 | 60.21 | 56.28 | 67.13 | 77.95 | 83.11 |
| Revenue Growth | — | -19.73% | -6.53% | 19.28% | 16.12% | 6.62% |
| − Expenses & Profitability | ||||||
| Operating Profit | 18.06 | 5.99 | -0.99 | 11.05 | 17.96 | 12.59 |
| OPM % | 24.03% | 9.89% | -1.74% | 16.09% | 22.79% | 14.96% |
| Profit Before Tax | 13.34 | 1.14 | -5.94 | 6.86 | 12.72 | 5.99 |
| − Bottom Line | ||||||
| Net Profit | 9.97 | -1.45 | -5.73 | 5.79 | 8.97 | 5.25 |
| Profit Growth | — | -114.54% | — | — | 54.92% | -41.47% |
| EPS | 99.74 | -1.32 | -5.21 | 5.27 | 8.15 | 3.48 |
| Dividend / Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Balance Sheet
Annual · ₹ CrLiabilities shown exclude shareholders’ funds and other equity. Assets equal liabilities plus equity.
| Particulars | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| − Equity | ||||||
| Shareholders' Funds | 5.14 | 11.70 | 5.96 | 11.76 | 20.73 | 58.55 |
| − Liabilities | ||||||
| Total Borrowings | 14.47 | 20.40 | 15.31 | 20.46 | 22.09 | 37.10 |
| Total Current Liabilities | 16.93 | 20.50 | 21.18 | 24.03 | 31.92 | 43.44 |
| Total Liabilities | 30.58 | 37.00 | 30.57 | 37.72 | 43.85 | 60.05 |
| − Assets | ||||||
| Fixed Assets | 15.61 | 25.06 | 23.67 | 30.64 | 39.61 | 58.28 |
| Investments | 4.86 | 5.29 | 0.11 | 0.21 | 0.23 | 16.97 |
| Cash & Equivalents | 1.69 | 4.64 | 0.15 | 0.41 | 0.78 | 9.40 |
| Total Current Assets | 15.01 | 17.89 | 12.26 | 18.05 | 23.83 | 43.35 |
| Total Assets | 35.72 | 48.70 | 36.54 | 49.49 | 64.57 | 118.60 |
Cash Flow
Annual · ₹ Cr| Particulars | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| − Cash Flows | ||||||
| Cash from Operations | 14.74 | 3.64 | -0.12 | 7.93 | 13.73 | 3.82 |
| Cash from Investing | -11.88 | -5.20 | 2.11 | -11.03 | -13.14 | -40.29 |
| Cash from Financing | -1.39 | 4.50 | -6.47 | 3.36 | -0.22 | 45.08 |
| Net Cash Flow | 1.46 | 2.94 | -4.48 | 0.26 | 0.37 | 8.62 |
| − Cash Position | ||||||
| Closing Cash | 1.69 | 4.64 | 0.15 | 0.41 | 0.78 | 9.40 |
Shareholding Pattern
Promoters hold 73.0% of MODERN DIAGNOSTIC & RESEARCH CENTRE, more than half. Since 7 Jan 2026, foreign institutions’ share has fallen from 1.1% to 0.0%.
| Holder | 7 Jan ’26 | Mar ’26 | Sep ’26 |
|---|---|---|---|
| Promoters | 72.9% | 72.9% | 73.0% |
| Foreign institutions FII | 1.1% | 0.0% | 0.0% |
| Indian institutions DII | 11.8% | 15.5% | 12.6% |
| Public | 14.3% | 11.6% | 14.5% |
Darker shading marks the quarters when that holder owned more.
Dividend History
No dividends are on record for MODERN DIAGNOSTIC & RESEARCH CENTRE.




